Ultrasound imaging of thyroid may identify cancers among low-risk patients; decrease rate of unnecessary thyroid biopsies.
Ultrasound imaging of the thyroid may help identify low-risk thyroid cancer patients, according to a study published in JAMA.
Researchers from the University of California, San Francisco, undertook a study to quantify the risk of thyroid cancer associated with thyroid nodules, based on ultrasound imaging characteristics.
The retrospective, case-controlled study assessed 8,806 patients who underwent 11,618 thyroid ultrasound examinations from January 2000 through March 2005. A total of 105 patients were subsequently diagnosed with thyroid cancer.
It was found that thyroid nodules were common among patients who had thyroid cancer (96.9 percent) and also among those who did not (56.4 percent).
The researchers noted that there were three ultrasound nodule characteristics that were only associated with the risk of thyroid cancer:
· Microcalcifications
· Size greater than 2 cm
· Entirely solid composition
It was determined that most cases of thyroid cancer could be detected if biopsies were performed based on using one characteristic as indication for the procedure. Two characteristics as basis for biopsy would bring the sensitivity and false-positive rates lower with a higher positive likelihood ratio.
These results showed the rate of unnecessary biopsies could be reduced by 90 percent while maintaining a low risk of cancer if there were a more stringent approach for performing biopsies, researchers said.
"Adoption of uniform standards for the interpretation of thyroid sonograms would be a first step toward standardizing the diagnosis and treatment of thyroid cancer and limiting unnecessary diagnostic testing and treatment," the study concluded.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Week, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.